Patents by Inventor Xiucai LIU

Xiucai LIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210180032
    Abstract: The invention relates to the directed evolution of CYP52A12 gene and the use thereof for the production of a dicarboxylic acid. In particular, it relates to a method of preparing a long chain dicarboxylic acid producing strain by using directed evolution and homologous recombination, a strain obtained by the method that is capable of producing a long chain dicarboxylic acid under an acidic condition and the use thereof. In particular, the invention relates to a method of preparing a long chain dicarboxylic acid producing strain by directed evolution of CYP52A12 gene and homologous recombination, a strain obtained by the method that is capable of producing a long chain dicarboxylic acid under an acidic condition and the use thereof. By directed evolution of CYP52A12 gene, one strain which has a base mutation at the promoter region of said gene and is capable of producing a long chain dicarboxylic acid under an acidic condition in a shortened fermentation time is screened out in the invention.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 17, 2021
    Applicants: CATHAY BIOTECH INC., CIBT AMERICA INC.
    Inventors: Wenbo LIU, Min XU, Howard CHOU, Xiucai LIU
  • Publication number: 20210164003
    Abstract: Provided microorganisms genetically modified to overexpress an imine/enamine deaminase to enhance the production of lysine and lysine derivatives by the microorganism. Also provided a method of generating such microorganism, and methods of producing lysine and lysine derivatives using the genetically modified microorganisms.
    Type: Application
    Filed: November 29, 2017
    Publication date: June 3, 2021
    Applicants: CATHAY BIOTECH INC., CIBT AMERICA INC.
    Inventors: Howard CHOU, Ling CHEN, Xiucai LIU
  • Publication number: 20210155962
    Abstract: The invention provides CadA polypeptides with mutations that increase activity in alkaline pH compared to the wild-type lysine decarboxylase. The invention also provides methods of generating such mutant polypeptides, microorganisms genetically modified to overexpress the mutant polypeptides, and methods of generating such microorganism.
    Type: Application
    Filed: May 16, 2017
    Publication date: May 27, 2021
    Inventors: Howard Chou, Wenqiang Lu, Ling Chen, Lijun Yu, Xiucai Liu
  • Patent number: 11008279
    Abstract: Provided is a method for purifying 1,5-pentanediamine comprising: providing 1,5-pentanediamine to be purified and treating the 1,5-pentanediamine to be purified by a reduction reaction to obtain purified 1,5-pentanediamine. Meanwhile, further provided is 1,5-pentanediamine prepared by the method. The purification method has a concise process and a simple operation, and is suitable for industrial production, and can significantly improve the quality of 1,5-pentanediamine.
    Type: Grant
    Filed: December 5, 2019
    Date of Patent: May 18, 2021
    Assignees: CATHAY BIOTECH INC., CIBT AMERICA INC.
    Inventors: Bingbing Qin, Charlie Liu, Shanshi Guo, Benliang Hou, Xiucai Liu
  • Patent number: 10982241
    Abstract: The invention relates to a long-chain dibasic acid with low content of monobasic acid impurity and a production method thereof, in particular to the preparation of a long-chain dibasic acid producing strain by means of directed evolution and homologous recombination, and to the production of a long-chain dibasic acid with low content of monobasic acid impurity by fermentation of said strain. The invention relates to a mutated CYP52A12 gene, homologous gene or variant thereof, which, relative to GenBank Accession Number AY230498 and taking the first base upstream of the start codon ATG as ?1, comprises a mutation. The invention relates to a strain comprising said mutated CYP52A12 gene, homologous gene or variant thereof wherein when the strain is fermented to produce a long-chain dibasic acid, the content of monobasic acid impurity in the fermentation product is significantly reduced.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: April 20, 2021
    Inventors: Wenbo Liu, Min Xu, Chen Yang, Howard Chou, Xiucai Liu
  • Publication number: 20210054423
    Abstract: The invention provides microorganisms genetically modified to overexpress biofilm dispersal related polypeptides to enhance the production of lysine and lysine derivatives by the microorganism, method of generating such microorganism, and methods of producing lysine and lysine derivatives using the genetically modified microorganisms.
    Type: Application
    Filed: January 9, 2018
    Publication date: February 25, 2021
    Applicants: CATHAY BIOTECH INC., CIBT AMERICA INC.
    Inventors: Howard CHOU, Ling CHEN, Yunfeng LEI, Xiucai LIU
  • Publication number: 20210040517
    Abstract: The present invention provides a decanedioic acid produced by microbial fermentation process, in which the content of C10 aliphatic acid and C10 hydroxy aliphatic acid is maintained at a very low level. The present invention also provides a preparation method of the decanedioic acid and a polymer prepared by using the decanedioic acid as monomer. The decanedioic acid provided by the present invention is prepared by microbial fermentation process. The decanedioic acid product which is produced through the processes of microbial fermentation and separation has a higher purity, a higher thermal stability, and a lower impurity content. The decanedioic acid provided by the present invention could satisfy the requirements of high grade product of polyamide or polyester to produce polymer with excellent qualities.
    Type: Application
    Filed: October 28, 2020
    Publication date: February 11, 2021
    Inventors: Min Xu, Yingli Hao, Chen Yang, Naiqiang Li, Xiucai Liu
  • Publication number: 20210024446
    Abstract: The present disclosure provides method for isolating a long chain dicarboxylic acid such as a substantially pure or pure long chain dicarboxylic acid from a fermentation broth containing microbial cells.
    Type: Application
    Filed: September 30, 2020
    Publication date: January 28, 2021
    Applicants: CATHAY BIOTECH INC., CIBT AMERICA, INC.
    Inventors: Bingbing QIN, Yufeng YANG, Xiucai LIU
  • Patent number: 10851394
    Abstract: The present invention provides a decanedioic acid produced by microbial fermentation process, in which the content of C10 aliphatic acid and C10 hydroxy aliphatic acid is maintained at a very low level. The present invention also provides a preparation method of the decanedioic acid and a polymer prepared by using the decanedioic acid as monomer. The decanedioic acid provided by the present invention is prepared by microbial fermentation process. The decanedioic acid product which is produced through the processes of microbial fermentation and separation has a higher purity, a higher thermal stability, and a lower impurity content. The decanedioic acid provided by the present invention could satisfy the requirements of high grade product of polyamide or polyester to produce polymer with excellent qualities.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: December 1, 2020
    Assignees: CATHAY BIOTECH INC., CIBT AMERICA INC.
    Inventors: Min Xu, Yingli Hao, Chen Yang, Naiqiang Li, Xiucai Liu
  • Patent number: 10807937
    Abstract: The present disclosure provides a method for isolating a long chain dicarboxylic acid from fermentation broth containing microbial cells. Also provided is a substantially pure long chain dicarboxylic acid isolated by the method.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: October 20, 2020
    Assignees: CATHAY BIOTECH INC., CIBT AMERICA INC.
    Inventors: Bingbing Qin, Yufeng Yang, Xiucai Liu
  • Patent number: 10759737
    Abstract: Provided is a method for extracting a 1,5-pentanediamine from a solution system containing a 1,5-pentanediamine salt. The method comprises adding to the solution system an insoluble basic substance to form a solution system containing free 1,5-pentanediamine. The provided method has high applicability, is easy to use, and is environmentally-friendly, significantly lowering raw material costs and operating costs for the entire manufacturing process. The method achieves a high recovery rate for pentanediamine, and is more suitable for industrial-scale production.
    Type: Grant
    Filed: September 7, 2016
    Date of Patent: September 1, 2020
    Assignees: CATHAY BIOTECH INC., CIBT AMERICA INC.
    Inventors: Xiucai Liu, Bingbing Qin, Chen Yang
  • Publication number: 20200255873
    Abstract: The invention provides microorganisms genetically modified to co-overexpress a carbohydrate binding module and lysine decarboxylase polypeptides in a mesophilic host to enhance the production of lysine derivatives by the microorganism, method of generating such microorganism, and methods of producing lysine derivatives using the genetically modified microorganisms.
    Type: Application
    Filed: September 22, 2017
    Publication date: August 13, 2020
    Inventors: Howard Chou, Ling Chen, Xiucai Liu
  • Publication number: 20200239919
    Abstract: The invention relates to a long-chain dibasic acid with low content of monobasic acid impurity and a production method thereof, in particular to the preparation of a long-chain dibasic acid producing strain by means of directed evolution and homologous recombination, and to the production of a long-chain dibasic acid with low content of monobasic acid impurity by fermentation of said strain. The invention relates to a mutated CYP52A12 gene, homologous gene or variant thereof, which, relative to GenBank Accession Number AY230498 and taking the first base upstream of the start codon ATG as ?1, comprises a mutation. The invention relates to a strain comprising said mutated CYP52A12 gene, homologous gene or variant thereof wherein when the strain is fermented to produce a long-chain dibasic acid, the content of monobasic acid impurity in the fermentation product is significantly reduced.
    Type: Application
    Filed: March 23, 2020
    Publication date: July 30, 2020
    Inventors: Wenbo LIU, Min XU, Chen YANG, Howard CHOU, Xiucai LIU
  • Publication number: 20200231999
    Abstract: The invention provides CadA polypeptides with mutations that increase activity in alkaline pH compared to the wild-type lysine decarboxylase. The invention also provides methods of generating such mutant polypeptides, microorganisms genetically modified to overexpress the mutant polypeptides, and methods of generating such microorganism.
    Type: Application
    Filed: December 30, 2016
    Publication date: July 23, 2020
    Applicants: CATHAY R&D CENTER CO., Ltd., CIBT AMERICA INC.
    Inventors: Howard CHOU, Wenqiang LU, Ling CHEN, Xiucai LIU
  • Publication number: 20200224226
    Abstract: The invention provides microorganisms genetically modified to overexpress thermophilic lysine decarboxylase polypeptides in a mesophilic host to enhance the production of lysine and lysine derivatives by the microorganism, method of generating such microorganism, and methods of producing lysine and lysine derivatives using the genetically modified microorganisms
    Type: Application
    Filed: July 6, 2017
    Publication date: July 16, 2020
    Inventors: Howard Chou, Xiucai Liu
  • Publication number: 20200157152
    Abstract: One aspect provided herein relates to lysine decarboxylase polypeptides comprising mutants of SEQ ID NO: 2 (i.e., mutants of Klebsiella oxytoca (K. oxytoca) Ldc) and/or fragments thereof. In certain embodiments, the mutants or fragments thereof may have at least about 95% sequence identity with SEQ ID NO: 2. Another aspect provided herein relates to a DNA polynucleotide comprising one or more lysine decarboxylase nucleotide sequences of mutants of SEQ ID NO: 1 (i.e., mutants of K. oxytoca ldc), fragments thereof, or fragments of SEQ ID NO: 1 (i.e., fragments of K. oxytoca ldc). In certain embodiments, the DNA polynucleotide as disclosed herein may encode one or more lysine decarboxylase polypeptides provided herein. In certain embodiments, the DNA polynucleotide as disclosed herein may encode SEQ ID NO: 2, mutants, and/or fragments thereof. In certain embodiments, the lysine decarboxylase nucleotide sequences provided herein may have at least 95% sequence identity with SEQ ID NO: 1 or SEQ ID NO: 3.
    Type: Application
    Filed: January 9, 2020
    Publication date: May 21, 2020
    Applicants: CATHAY BIOTECH INC., CIBT AMERICA INC.
    Inventors: Howard CHOU, Naiqiang LI, Xiucai LIU
  • Patent number: 10647976
    Abstract: The expression plasmid vectors comprise a polynucleotide sequence encoding Ldc2 polypeptide, a fragment, and/or a mutant. A backbone plasmid is capable of autonomous replication in a host cell. The host cell is not a P. aeruginosa cell. Transformants are transformed with expression plasmid vector. The transformants are not P. aeruginosa. Mutant host cells comprise a polynucleotide sequence encoding Ldc2 polypeptide, a fragment and/or a mutant that has been integrated into the host cell chromosome. A polypeptide, a fragment and/or a mutant comprise Ldc2. A non-naturally occurring polynucleotide, and/or a mutant encodes polypeptide comprising Ldc2. Biobased cadaverine is produced using the transformants and the biobased cadaverine is prepared by the method. Polyamides are formed using the biobased cadaverine and compositions.
    Type: Grant
    Filed: June 26, 2014
    Date of Patent: May 12, 2020
    Assignees: Cathay Biotech Inc., CIBT America Inc
    Inventors: Howard Chou, Naiqiang Li, Xiucai Liu
  • Patent number: 10619148
    Abstract: Provided are a lysine decarboxylase immobilized cell and preparation method thereof.
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: April 14, 2020
    Assignees: Cathay Biotech Inc., CIBT America Inc.
    Inventors: Lijun Yu, Naiqiang Li, Charlie Liu, Xiucai Liu
  • Publication number: 20200109104
    Abstract: Provided is a method for purifying 1,5-pentanediamine comprising: providing 1,5-pentanediamine to be purified and treating the 1,5-pentanediamine to be purified by a reduction reaction to obtain purified 1,5-pentanediamine. Meanwhile, further provided is 1,5-pentanediamine prepared by the method. The purification method has a concise process and a simple operation, and is suitable for industrial production, and can significantly improve the quality of 1,5-pentanediamine.
    Type: Application
    Filed: December 5, 2019
    Publication date: April 9, 2020
    Applicants: CIBTAmerica Inc., Cathay Biotech Inc.
    Inventors: Bingbing Qin, Charlie Liu, Shanshi Guo, Benliang Hou, Xiucai Liu
  • Patent number: 10612055
    Abstract: Provided herein is a genetically modified host cell comprising a heterologous nucleic acid encoding a biofilm dispersal polypeptide that decreases intracellular c-di-GMP levels and enhances the production of lysine and lysine derivatives. Further provided are methods of generating such cell and producing lysine and lysine derivatives using the genetically modified host cell.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: April 7, 2020
    Assignees: Cathay Biotec Inc., CIBT America Inc.
    Inventors: Howard Chou, Xiucai Liu